Literature DB >> 1715623

Tenascin gene expression in rat liver and in rat liver cells. In vivo and in vitro studies.

G Ramadori1, S Schwögler, T Veit, H Rieder, R Chiquet-Ehrismann, E J Mackie, K H Meyer zum Büschenfelde.   

Abstract

Tenascin is a major glycoprotein constituent of the extracellular matrix with a strong affinity to fibronectin; its distribution is believed to be temporarily and spatially limited. Tenascin gene expression is increased during wound healing processes. As repair mechanisms in chronic liver diseases resemble wound healing we studied tenascin gene expression in rat liver and in isolated rat liver cells. In normal rat liver a tenascin specific antiserum stains sinusoidal cells with fiber-like prolongations, which at the same time are desmin-positive (ITO-cells). In the CCl4-acutely-damaged liver a strong tenascin staining is detected in cells located among the mononuclear cells of the inflammatory infiltrates in the areas of necrosis and in cells of the sinusoids. In CCl4-chronically-damaged liver a strong tenascin staining is demonstrable in the connective tissue septa. In both cases, many of the tenascin-positive cells can be identified as desmin-positive by means of the double-staining fluorescence technique. The wall of larger vessels is always tensacin-negative. The staining pattern obtained with a fibronectin-specific antiserum is somewhat comparable with that of tenascin but the vessel wall was positive. hepatocytes, Kupffer cells, ITO-cells and endothelial cells were isolated from rat liver and studied for their capacity to express the tenascin gene. Biosynthetically labeled tenascin was immunoprecipated from supernatants and cell lysates obtained from cultured ITO-cells and to a much lesser extent from intracellular lysates obtained from endothelial cells; its synthesis in ITO-cells increased during the time in culture. Tenascin was also identified immuno-cytochemically in increasing amount in ITO-cells in culture.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715623     DOI: 10.1007/bf02899540

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  7 in total

Review 1.  Molecular mechanisms of hepatic fibrosis and principles of therapy.

Authors:  S L Friedman
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

2.  Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.

Authors:  M Gallai; I Kovalszky; T Knittel; K Neubauer; T Armbrust; G Ramadori
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 3.  The hepatic extracellular matrix. I. Components and distribution in normal liver.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.

Authors:  Masashi Tamaoki; Kyoko Imanaka-Yoshida; Kazuto Yokoyama; Tomohiro Nishioka; Hiroyasu Inada; Michiaki Hiroe; Teruyo Sakakura; Toshimichi Yoshida
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

5.  Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair.

Authors:  T Knittel; S Aurisch; K Neubauer; S Eichhorst; G Ramadori
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

6.  Synergistic effects of tethered growth factors and adhesion ligands on DNA synthesis and function of primary hepatocytes cultured on soft synthetic hydrogels.

Authors:  Geeta Mehta; Courtney M Williams; Luis Alvarez; Martha Lesniewski; Roger D Kamm; Linda G Griffith
Journal:  Biomaterials       Date:  2010-03-21       Impact factor: 12.479

Review 7.  It's all about the spaces between cells: role of extracellular matrix in liver fibrosis.

Authors:  Amit Khurana; Nilofer Sayed; Prince Allawadhi; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2021-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.